Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
From Risk to Results: Cases in ASCVD Prevention and Treatment
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
Statins and Safety: What the Data Say About Dementia, Cancer, and More
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
When and Why to Use CAC Scoring
Bridging ASCVD Care Between Academic and Rural Settings
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
Target in Sight: Escalating Therapy to Reach LDL-C Goals
The Dose Matters: Optimizing Statin Intensity in ASCVD Management
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Riccardo Maria Inciardi, MD, PhD
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
prof. Hiddo Heerspink
Jennifer B. Green, MD
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Valeria Caso, MD, PhD
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
Alexander T. Cohen, MD, MBBS
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.